Convatec is submitting this report as a result of remediation activities related to the fda 483 issued april 16, 2014.Device(s) listed in this report is (are) used for treatment, not diagnosis.Any additional information received regarding this event after filing this report shall be filed on a supplemental mdr.The batch record review for lot 1j00923 was performed.No discrepancies were noted in these batch records related to the complaint reported.The retained product was evaluated and the evaluation results are as follows: the samples were visually inspected and all samples appeared to be in normal condition.It is noted that there are blank areas on this form, the information was not provided or is unknown.
|